Long-Term Evolocumab in Patients With Familial Hypercholesterolemia (2020)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacc.2019.12.020
- Subjects: HIPERCOLESTEROLEMIA; ANTICORPOS MONOCLONAIS; ENZIMAS PROTEOLÍTICAS; ANTIMETABÓLITOS; RESULTADO DE TRATAMENTO
- Agências de fomento:
- Medicines Company
- Arrowhead
- Kowa
- Gemphire
- Regeneron
- Merck Sharp DohmeMerck & Company
- PfizerPfizer
- AlexionFukuda Foundation for Medical TechnologySasagawa Scientific Research GrantKayamori FoundationKayamori Foundation of Informational Science AdvancementSENSHIN Medical Research Foundation
- Sanofi-Genzyme
- Amryt
- Akcea
- Synageva
- Aegerion
- AstraZenecaAstraZeneca
- Sanofi
- European UnionEuropean Union (EU)
- ZonMWNetherlands Organization for Health Research and Development
- Conselho Nacional de Pesquisa e Desenvolvimento TecnologicoNational Council for Scientific and Technological Development (CNPq) [303734/2018-3]
- AmgenAmgen
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the american college of cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 75, n. 6, p. 565-574, 2020
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SANTOS FILHO, Raul Dias dos et al. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 75, n. 6, p. 565-574, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.12.020. Acesso em: 06 maio 2026. -
APA
Santos Filho, R. D. dos, Stein, E. A., Hovingh, G. K., Blom, D. J., Soran, H., Watts, G. F., et al. (2020). Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. Journal of the american college of cardiology, 75( 6), 565-574. doi:10.1016/j.jacc.2019.12.020 -
NLM
Santos Filho RD dos, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, Lopez JAG, Bray S, Kurtz CE, Hamer AW. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2020 ; 75( 6): 565-574.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.jacc.2019.12.020 -
Vancouver
Santos Filho RD dos, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, Lopez JAG, Bray S, Kurtz CE, Hamer AW. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2020 ; 75( 6): 565-574.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.jacc.2019.12.020 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
